Japan's Pharmaceuticals and Medical Devices Agency granted priority review to the New Drug Application for sonpiretigene ...
Sharon Fekrat, MD, FACS, FASRS, discusses how retinal imaging fits into the diagnostic picture for CVI, TBI, and ...
Nimesh Patel, MD, urges the FDA to reconsider SYD-101 as pediatric myopia drives earlier retinal damage in US children. In ...
Sequencing IOL choice by eye can ease patient decision paralysis.
Lakhanpal said his first goal with a newly diagnosed patient is to confirm the diagnosis and talk about GA in general. He ...
In recognition of CVI Awareness Day on September 29, 2026, and as part of the Eye Care Network’s CVI Awareness Month coverage ...
One of the defining features of the Ophthalmology Times and Optometry Times EyeCon 2026, held virtually on September 26, 2026 ...
Nimesh A. Patel, MD, explains why myopia-related retinal detachments are appearing earlier and how routine exams can catch ...
Aldeyra Therapeutics, Inc. plans to submit a Formal Dispute Resolution Request (FDRR) to the FDA for reproxalap, its investigational drug candidate for dry eye disease. The request appeals the March ...
Tarcocimab, tabirafusp-ted were noninferior to aflibercept in DAYBREAK wet AMD trial; 54% on tarcocimab reached 24-week dosing.
Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...
Coats, OD, FAAO, explains how neurotrophic keratitis, demodex, cosmetic habits and mucus fishing complicate dry eye disease. Following the session, the Eye Care Network asked Coats about the ocular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results